General - Press Releases

Date	Title	Company
14-Dec-2023	USAntibiotics Expands Leadership Team with Appointment of Steven Lutz to Vice President of Strategic Accounts	Businesswire
14-Dec-2023	Maze Therapeutics Announces Initiation of Dosing in Phase 1 Trial Evaluating MZE829, a Novel Oral APOL1 Inhibitor, as a Potential Treatment for APOL1 Kidney Disease	Businesswire
14-Dec-2023	Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma	Businesswire
14-Dec-2023	Parse Biosciences Closes $50 Million of Financing to Fuel Continued Worldwide Growth	Businesswire
14-Dec-2023	CinFina Pharma, a CinRx Portfolio Company, Introduces Scientific Advisory Board with Deep Metabolic Expertise	Businesswire
14-Dec-2023	Dr. Reddy’s becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index	Businesswire
14-Dec-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
14-Dec-2023	Global $5.63 Bn Reefer Truck Market Trends, Opportunity, and Forecast, 2018-2028 - ResearchAndMarkets.com	Businesswire
14-Dec-2023	Pfizer Completes Acquisition of Seagen	Businesswire
14-Dec-2023	MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120 in Generalized Anxiety Disorder	Businesswire
14-Dec-2023	Neochromosome Announces Collaboration with University of Edinburgh Creating Defined Variant Libraries for Designer Enzymes	Businesswire
14-Dec-2023	Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day	Businesswire
14-Dec-2023	Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)	Businesswire
14-Dec-2023	Amide Technologies Announces Complex Peptide Manufacturing Platform, Raises $16.5M to Expedite Frontier Drug Discovery	Businesswire
14-Dec-2023	ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for Women with Postpartum Depression (PPD), is Now Available in the U.S.	Businesswire
14-Dec-2023	Steel Connect Reports First Quarter Fiscal 2024 Financial Results	Businesswire
14-Dec-2023	Global Hematology Analyzers Pipeline Research Report 2023: Stages of Development, Segments, Region, Regulatory Path and Key Companies - ResearchAndMarkets.com	Businesswire
14-Dec-2023	Nerviano Medical Sciences and Italfarmaco Announce Licensing of Linker-Payload Technology to Develop and Commercialize a Novel Peptide-Drug Conjugate	Businesswire
14-Dec-2023	IBSA and Her Skipper Alberto Bona Win the 2023 Class40 Championship	Businesswire
14-Dec-2023	STORM Therapeutics’ First-in-Class tRNA methyltransferase inhibitor of METTL1 to be Presented at the 65th Annual ASH Conference	STORM